These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11974678)

  • 1. FDA approves NuvaRing contraceptive implant.
    J Gend Specif Med; 2002; 5(2):6. PubMed ID: 11974678
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction. NuvaRing.
    Milsom I
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():11; discussion 37-9. PubMed ID: 12659396
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete and robust ovulation inhibition with NuvaRing.
    Killick S
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():13-8; discussion 37-9. PubMed ID: 12659397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
    Roumen F
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():19-24; discussion 37-9. PubMed ID: 12659398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New forms of hormonal contraception].
    Gaspard U; Buicu C; van den Brûle F
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):288-91. PubMed ID: 10804374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower hormone dosage with improved cycle control.
    Vree M
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():25-30; discussion 37-9. PubMed ID: 12659399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
    Sarkar NN
    Eur J Contracept Reprod Health Care; 2005 Jun; 10(2):73-8. PubMed ID: 16147810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
    Milsom I; Lete I; Bjertnaes A; Rokstad K; Lindh I; Gruber CJ; Birkhäuser MH; Aubeny E; Knudsen T; Bastianelli C
    Hum Reprod; 2006 Sep; 21(9):2304-11. PubMed ID: 16763008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH; Dieben TO
    Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High acceptability and satisfaction with NuvaRing use.
    Szarewski A
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():31-6; discussion 37-9. PubMed ID: 12659400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined contraceptive ring NuvaRing and spermicide co-medication.
    Haring T; Mulders TM
    Contraception; 2003 Apr; 67(4):271-2. PubMed ID: 12684146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
    Novák A; de la Loge C; Abetz L; van der Meulen EA
    Contraception; 2003 Mar; 67(3):187-94. PubMed ID: 12618252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
    Roumen FJ; op ten Berg MM; Hoomans EH
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):14-22. PubMed ID: 16546812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improved hormone implant provides 3 years of contraception. The end of the pill?. Interview by Petra Eiden].
    Hoffmann KO
    MMW Fortschr Med; 2000 Mar; 142(11):16. PubMed ID: 10786083
    [No Abstract]   [Full Text] [Related]  

  • 17. Duramed Pharmaceuticals targets women's health.
    Contracept Technol Update; 2000 Feb; 21(2):19-21. PubMed ID: 12295619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Implanon insertion and removal.
    Levine JP; Sinofsky FE; Christ MF;
    Contraception; 2008 Nov; 78(5):409-17. PubMed ID: 18929739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
    Roumen FJ; Dieben TO
    Fertil Steril; 2006 Jan; 85(1):57-62. PubMed ID: 16412731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraceptive vaginal ring.
    Madden T; Blumenthal P
    Clin Obstet Gynecol; 2007 Dec; 50(4):878-85. PubMed ID: 17982330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.